0.00Open0.00Pre Close0 Volume0 Open Interest30.00Strike Price0.00Turnover189.69%IV-43.51%PremiumMay 16, 2025Expiry Date23.11Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9822Delta0.0028Gamma2.28Leverage Ratio-0.0392Theta0.0069Rho2.24Eff Leverage0.0036Vega
PROCEPT BioRobotics Stock Discussion
PROCEPT Crushes Q1 Expectations: 55% Revenue Growth, International Sales Double, 2025 Guidance Raised
📊⚡️📊
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
No comment yet